Hyundai Bioscience Co

Hyundai Bioscience Co Current Assets

The Current Assets of Hyundai Bioscience Co (048410.KQ) as of Nov 15, 2026 is 1.14 B KRW. In the previous year, Current Assets was 1.08 B KRW — a change of 5.67% (higher).

Current Assets

1.14 BKRW

YoY

5.67%

Last updated:

Current Assets of Hyundai Bioscience Co is 2025 1.14 B KRW. Current Assets of Hyundai Bioscience Co was 2024 1.08 B KRW. It decreases by 5.67% higher compared to the previous year.

The Hyundai Bioscience Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
35.39 B KRW
Jan 1, 2019
32.82 B KRW
Jan 1, 2020
41.68 B KRW
Jan 1, 2021
34.60 B KRW
Jan 1, 2022
23.42 B KRW
Jan 1, 2023
2.59 B KRW
Jan 1, 2024
1.08 B KRW
Jan 1, 2025
1.14 B KRW
The Hyundai Bioscience Co Current Assets history
YEARCurrent AssetsYoY
1.14 BKRW+5.67%
1.08 BKRW-58.43%
2.59 BKRW-88.95%
23.42 BKRW-32.32%
34.60 BKRW-16.98%
41.68 BKRW+26.99%
32.82 BKRW-7.26%
35.39 BKRW-1.45%
35.91 BKRW-4.22%
37.49 BKRW+10.22%
34.02 BKRW+69.13%
20.11 BKRW+7.82%
18.66 BKRW+1.60%
18.36 BKRW-9.82%
20.36 BKRW-45.91%
37.64 BKRW-14.08%
43.81 BKRW-8.81%
48.04 BKRW-15.35%
56.76 BKRW-26.57%
77.29 BKRW-39.81%
128.42 BKRW-0.61%
129.21 BKRW-7.38%
139.50 BKRW+22.56%
113.83 BKRW+129.94%
49.50 BKRW+20.67%
41.02 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyundai Bioscience Co Stock analysis

What does Hyundai Bioscience Co do? Hyundai Bioscience Co., Ltd. generates revenue through the manufacturing and sale of bio-cosmetics and hair tonics, including functional daily necessities like shampoos, mask packs, and creams. The company also develops tumor-targeted drugs and sells LCD monitors and digital signage display products. Domestic and overseas markets, including Europe, America, and Japan, purchase these products, with the firm distributing its offerings across these regions. The company's product portfolio features bio-cosmetics, hair tonics, shampoos, mask packs, creams, tumor-targeted drugs, LCD monitors, and digital signage displays. These items are sold to customers in both domestic and international markets, with Europe, America, and Japan representing key overseas segments. The firm focuses on functional daily necessities and display technology products as its core revenue streams. Hyundai Bioscience Co., Ltd. targets consumers seeking bio-based personal care products and businesses requiring display solutions. Its domestic market serves local customers, while international segments in Europe, America, and Japan drive global sales. The company’s revenue model combines consumer goods sales with technology-oriented product distribution. Hyundai Bioscience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyundai Bioscience Co stock

Current Assets of Hyundai Bioscience Co is 1.14 B KRW in 2025.

Current Assets of Hyundai Bioscience Co changed from 1.08 B KRW to 1.14 B KRW, representing a 5.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Hyundai Bioscience Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Hyundai Bioscience Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Hyundai Bioscience Co

All Key Metrics — Hyundai Bioscience Co